Hearing aids: indications, technology, adaptation, and quality control
- PMID: 29279726
- PMCID: PMC5738937
- DOI: 10.3205/cto000147
Hearing aids: indications, technology, adaptation, and quality control
Abstract
Hearing loss can be caused by a number of different pathological conditions. Some of them can be successfully treated, mainly by surgery, depending on the individual's disease process. However, the treatment of chronic sensorineural hearing loss with damaged cochlear structures usually needs hearing rehabilitation by means of technical amplification. During the last two decades tremendous improvements in hearing aid technology led to a higher quality of the hearing rehabilitation process. For example, due to sophisticated signal processing acoustic feedback could be reduced and hence open fitting options are available even for more subjects with higher degrees of hearing loss. In particular for high-frequency hearing loss, the use of open fitting is an option. Both the users' acceptance and the perceived sound quality were significantly increased by open fittings. However, we are still faced with a low level of readiness in many hearing impaired subjects to accept acoustic amplification. Since ENT specialists play a key-role in hearing aid provision, they should promote early hearing aid rehabilitation and include this in the counselling even in subjects with mild and moderate hearing loss. Recent investigations demonstrated the benefit of early hearing aid use in this group of patients since this may help to reduce subsequent damages as auditory deprivation, social isolation, development of dementia, and cognitive decline. For subjects with tinnitus, hearing aids may also support masking by environmental sounds and enhance cortical inhibition. The present paper describes the latest developments of hearing aid technology and the current state of the art for amplification modalities. Implications for both hearing aid indication and provision are discussed.
Keywords: audio therapy; hearing aid; hearing loss; rehabilitation; tinnitus.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie eV. Leitlinie Hörsturz. Registernummer 017-010. AWMF; 2014. Available from: http://www.awmf.org/leitlinien/detail/ll/017-010.html.
-
- Sng J, Lufkin T. Filling the silent void: genetic therapies for hearing impairment. Genet Res Int. 2012;2012:748698. doi: 10.1155/2012/748698. Available from: http://dx.doi.org/10.1155/2012/748698. - DOI - DOI - PMC - PubMed
-
- Kohrman DC, Raphael Y. Gene therapy for deafness. Gene Ther. 2013 Dec;20(12):1119–1123. doi: 10.1038/gt.2013.39. Available from: http://dx.doi.org/10.1038/gt.2013.39. - DOI - DOI - PMC - PubMed
-
- Atkinson PJ, Wise AK, Flynn BO, Nayagam BA, Hume CR, O'Leary SJ, Shepherd RK, Richardson RT. Neurotrophin gene therapy for sustained neural preservation after deafness. PLoS ONE. 2012;7(12):e52338. doi: 10.1371/journal.pone.0052338. Available from: http://dx.doi.org/10.1371/journal.pone.0052338. - DOI - DOI - PMC - PubMed
-
- Needham K, Minter RL, Shepherd RK, Nayagam BA. Challenges for stem cells to functionally repair the damaged auditory nerve. Expert Opin Biol Ther. 2013 Jan;13(1):85–101. doi: 10.1517/14712598.2013.728583. Available from: http://dx.doi.org/10.1517/14712598.2013.728583. - DOI - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
